Amgen köper Onyx

Mångmiljardsumma när amerikanska Amgen köper upp branschkollegan.

By Nyhetsbyrån Direkt

August 26, 2013 12:00 AM

Det amerikanska

bioteknikbolaget Amgen köper Onyx Pharmaceuticals för 125 dollar per aktie, motsvarande 10,4 miljarder dollar, motsvarande ungefär 67 miljarder kronor. Det framgår av ett pressmeddelande.

Onyx Pharmaceuticals

är ett amerikanskt bioteknikbolag med inriktning på cancerbehandling. Affären väntas slutföras under fjärde kvartalet.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.